In this study, we have demonstrated that SMS inhibition by a small compound, Dy105, resulted into a significant decrease of plasma membrane SM levels, a significant reduction of BLp production from a hepatoma cell line, and a significant reduction of endotoxin-mediated NFκB and p38 activation in macrophages. Here, SMS is linked to hepatocellular carcinoma.